rs35106300

Variant summary

Our verdict is Benign. Variant got -16 ACMG points: 0P and 16B. BP4_StrongBP6_Very_StrongBS2

The NM_004840.3(ARHGEF6):​c.362G>A​(p.Arg121His) variant causes a missense change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.00565 in 1,209,615 control chromosomes in the GnomAD database, including 17 homozygotes. There are 2,151 hemizygotes in GnomAD. In-silico tool predicts a benign outcome for this variant. 14/20 in silico tools predict a benign outcome for this variant. Variant has been reported in ClinVar as Likely benign (★★).

Frequency

Genomes: 𝑓 0.0039 ( 1 hom., 121 hem., cov: 23)
Exomes 𝑓: 0.0058 ( 16 hom. 2030 hem. )

Consequence

ARHGEF6
NM_004840.3 missense

Scores

1
16

Clinical Significance

Benign/Likely benign criteria provided, multiple submitters, no conflicts B:9

Conservation

PhyloP100: 0.744
Variant links:
Genes affected
ARHGEF6 (HGNC:685): (Rac/Cdc42 guanine nucleotide exchange factor 6) Rho GTPases play a fundamental role in numerous cellular processes that are initiated by extracellular stimuli that work through G protein coupled receptors. The encoded protein belongs to a family of cytoplasmic proteins that activate the Ras-like family of Rho proteins by exchanging bound GDP for GTP. It may form a complex with G proteins and stimulate Rho-dependent signals. This protein is activated by PI3-kinase. Mutations in this gene can cause X-chromosomal non-specific cognitive disability. [provided by RefSeq, Jul 2008]

Genome browser will be placed here

ACMG classification

Classification made for transcript

Verdict is Benign. Variant got -16 ACMG points.

BP4
Computational evidence support a benign effect (MetaRNN=0.0059680343).
BP6
Variant X-136745320-C-T is Benign according to our data. Variant chrX-136745320-C-T is described in ClinVar as [Likely_benign]. Clinvar id is 128447.Status of the report is criteria_provided_multiple_submitters_no_conflicts, 2 stars. Variant chrX-136745320-C-T is described in Lovd as [Likely_benign]. Variant chrX-136745320-C-T is described in Lovd as [Benign].
BS2
High Hemizygotes in GnomAd4 at 121 XL gene

Transcripts

RefSeq

Gene Transcript HGVSc HGVSp Effect #exon/exons MANE Protein UniProt
ARHGEF6NM_004840.3 linkuse as main transcriptc.362G>A p.Arg121His missense_variant 4/22 ENST00000250617.7 NP_004831.1

Ensembl

Gene Transcript HGVSc HGVSp Effect #exon/exons TSL MANE Protein Appris UniProt
ARHGEF6ENST00000250617.7 linkuse as main transcriptc.362G>A p.Arg121His missense_variant 4/221 NM_004840.3 ENSP00000250617 P1Q15052-1
ARHGEF6ENST00000370622.5 linkuse as main transcriptc.-101G>A 5_prime_UTR_variant 3/211 ENSP00000359656 Q15052-2
ARHGEF6ENST00000370620.5 linkuse as main transcriptc.-101G>A 5_prime_UTR_variant 3/212 ENSP00000359654 Q15052-2

Frequencies

GnomAD3 genomes
AF:
0.00394
AC:
441
AN:
111879
Hom.:
1
Cov.:
23
AF XY:
0.00355
AC XY:
121
AN XY:
34077
show subpopulations
Gnomad AFR
AF:
0.000813
Gnomad AMI
AF:
0.00
Gnomad AMR
AF:
0.00227
Gnomad ASJ
AF:
0.00
Gnomad EAS
AF:
0.00
Gnomad SAS
AF:
0.00297
Gnomad FIN
AF:
0.00516
Gnomad MID
AF:
0.00
Gnomad NFE
AF:
0.00656
Gnomad OTH
AF:
0.00264
GnomAD3 exomes
AF:
0.00463
AC:
850
AN:
183462
Hom.:
2
AF XY:
0.00471
AC XY:
320
AN XY:
67898
show subpopulations
Gnomad AFR exome
AF:
0.000608
Gnomad AMR exome
AF:
0.00266
Gnomad ASJ exome
AF:
0.000134
Gnomad EAS exome
AF:
0.00
Gnomad SAS exome
AF:
0.00299
Gnomad FIN exome
AF:
0.00757
Gnomad NFE exome
AF:
0.00691
Gnomad OTH exome
AF:
0.00530
GnomAD4 exome
AF:
0.00582
AC:
6389
AN:
1097685
Hom.:
16
Cov.:
30
AF XY:
0.00559
AC XY:
2030
AN XY:
363063
show subpopulations
Gnomad4 AFR exome
AF:
0.000644
Gnomad4 AMR exome
AF:
0.00287
Gnomad4 ASJ exome
AF:
0.000258
Gnomad4 EAS exome
AF:
0.00
Gnomad4 SAS exome
AF:
0.00260
Gnomad4 FIN exome
AF:
0.00911
Gnomad4 NFE exome
AF:
0.00658
Gnomad4 OTH exome
AF:
0.00462
GnomAD4 genome
AF:
0.00394
AC:
441
AN:
111930
Hom.:
1
Cov.:
23
AF XY:
0.00354
AC XY:
121
AN XY:
34138
show subpopulations
Gnomad4 AFR
AF:
0.000811
Gnomad4 AMR
AF:
0.00227
Gnomad4 ASJ
AF:
0.00
Gnomad4 EAS
AF:
0.00
Gnomad4 SAS
AF:
0.00298
Gnomad4 FIN
AF:
0.00516
Gnomad4 NFE
AF:
0.00657
Gnomad4 OTH
AF:
0.00261
Alfa
AF:
0.00561
Hom.:
271
Bravo
AF:
0.00338
TwinsUK
AF:
0.00701
AC:
26
ALSPAC
AF:
0.00762
AC:
22
ESP6500AA
AF:
0.000261
AC:
1
ESP6500EA
AF:
0.00476
AC:
32
ExAC
AF:
0.00506
AC:
614
EpiCase
AF:
0.00573
EpiControl
AF:
0.00569

ClinVar

Significance: Benign/Likely benign
Submissions summary: Benign:9
Revision: criteria provided, multiple submitters, no conflicts
LINK: link

Submissions by phenotype

not specified Benign:4
Benign, criteria provided, single submitterclinical testingAmbry GeneticsDec 29, 2015This alteration is classified as benign based on a combination of the following: seen in unaffected individuals, population frequency, intact protein function, lack of segregation with disease, co-occurrence, RNA analysis, in silico models, amino acid conservation, lack of disease association in case-control studies, and/or the mechanism of disease or impacted region is inconsistent with a known cause of pathogenicity. -
Benign, criteria provided, single submitterclinical testingEurofins Ntd Llc (ga)Feb 06, 2014- -
Benign, criteria provided, single submitterclinical testingGenetic Services Laboratory, University of ChicagoMay 08, 2013- -
Benign, no assertion criteria providedclinical testingGenome Diagnostics Laboratory, University Medical Center Utrecht-- -
not provided Benign:3
Likely benign, criteria provided, single submitterclinical testingLabcorp Genetics (formerly Invitae), LabcorpDec 31, 2019- -
Likely benign, no assertion criteria providedclinical testingClinical Genetics DNA and cytogenetics Diagnostics Lab, Erasmus MC, Erasmus Medical Center-- -
Likely benign, no assertion criteria providedclinical testingLaboratory of Diagnostic Genome Analysis, Leiden University Medical Center (LUMC)-- -
ARHGEF6-related disorder Benign:1
Benign, no assertion criteria providedclinical testingPreventionGenetics, part of Exact SciencesMar 27, 2019This variant is classified as benign based on ACMG/AMP sequence variant interpretation guidelines (Richards et al. 2015 PMID: 25741868, with internal and published modifications). -
Intellectual disability, X-linked 46 Benign:1
Likely benign, no assertion criteria providedclinical testingDiagnostic Laboratory, Department of Genetics, University Medical Center Groningen-- -

Computational scores

Source: dbNSFP v4.3

Name
Calibrated prediction
Score
Prediction
AlphaMissense
Benign
0.073
BayesDel_addAF
Benign
-0.68
T
BayesDel_noAF
Benign
-0.75
CADD
Benign
17
DANN
Uncertain
0.98
DEOGEN2
Benign
0.16
T
FATHMM_MKL
Benign
0.40
N
LIST_S2
Benign
0.80
T
M_CAP
Benign
0.012
T
MetaRNN
Benign
0.0060
T
MetaSVM
Benign
-1.0
T
MutationAssessor
Benign
1.7
L
MutationTaster
Benign
1.0
N;N;N;N
PrimateAI
Benign
0.27
T
PROVEAN
Benign
-0.74
N
REVEL
Benign
0.026
Sift
Benign
0.076
T
Sift4G
Benign
0.58
T
Polyphen
0.0
B
Vest4
0.014
MVP
0.54
MPC
0.35
ClinPred
0.0060
T
GERP RS
3.5
Varity_R
0.073
gMVP
0.19

Splicing

Name
Calibrated prediction
Score
Prediction
SpliceAI score (max)
0.010
Details are displayed if max score is > 0.2

Find out detailed SpliceAI scores and Pangolin per-transcript scores at spliceailookup.broadinstitute.org

Publications

LitVar

Below is the list of publications found by LitVar. It may be empty.

Other links and lift over

dbSNP: rs35106300; hg19: chrX-135827479; COSMIC: COSV105077558; API